MoneyWorks4Me

A fair growth of 5.27% in the revenue at Rs. 9533.80 millions was reported in the September 2023 quarter as compared to Rs. 9056.10 millions during year-ago period.A slim rise of 11.36% was recorded in the Net profit for the quarter ended September 2023 to Rs. 2155.40  millions  From Rs. 1935.60 millions.Operating profit for the quarter ended September 2023 rose to 3150.50 millions as compared to 2790.80 millions of corresponding quarter ended September 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 9533.80 9056.10 5.27 16914.00 16350.70 3.45 32163.40 32175.10 -0.04
Other Income 284.70 221.60 28.47 652.70 499.50 30.67 1015.20 762.20 33.19
PBIDT 3150.50 2790.80 12.89 4931.00 4548.00 8.42 9009.30 8320.50 8.28
Interest 4.30 3.90 10.26 7.10 10.70 -33.64 18.10 19.90 -9.05
PBDT 3146.20 2786.90 12.89 5096.90 4537.30 12.33 8981.50 8416.40 6.71
Depreciation 181.10 163.60 10.70 344.70 321.80 7.12 657.70 681.90 -3.55
PBT 2965.10 2623.30 13.03 4752.20 4215.50 12.73 8323.80 7734.50 7.62
TAX 809.70 687.70 17.74 1291.00 1123.60 14.90 2276.80 3968.70 -42.63
Deferred Tax -96.30 -46.30 107.99 -141.30 -81.00 74.44 -183.70 -105.00 74.95
PAT 2155.40 1935.60 11.36 3461.20 3091.90 11.94 6047.00 3765.80 60.58
Equity 1694.10 1694.10 0.00 1694.10 1694.10 0.00 1694.10 1694.10 0.00
PBIDTM(%) 33.05 30.82 7.23 29.15 27.82 4.81 28.01 25.86 8.32
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1145.25
Cipla 1359.75
Lupin 2047.20
Zydus Lifesciences 1105.00
View more..